Celestoderm B, cream 0.1% 15 g

Pharmacodynamics
Betamethasone has anti-inflammatory and anti-allergic effect by inhibiting the release of cytokines and inflammatory mediators, reducing the metabolism of arachidonic acid, inducing the formation of lipocortins, which have anti-edema activity, reducing vascular permeability.

Micro dispersion of this GKS in a non-greasy, odorless, leaving no residue on clothes and easily washed off ointment or cream base ensures effective penetration into the skin and quick start of action.

Indications

Inflammatory skin diseases amenable to glucocorticosteroid (GCS) therapy:
– eczema (atonic, pediatric, montiform);
– contact dermatitis;
– seborrheic dermatitis;
– neurodermitis;
– sun dermatitis;
– exfoliative dermatitis;
– radiation dermatitis;
– intertriginous dermatitis;
– psoriasis;
– anogenital and senile itching.

Active ingredient

Composition

How to take, the dosage

Special Instructions

Contraindications

Side effects

The following adverse events have been reported with topical GKS: burning, irritation, dry skin, folliculitis, hypertrichosis, acne, hypopigmentation, neutral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, stretch marks, and sweat.

Overdose

Pregnancy use

Because the safety of topical GCS in pregnant women has not been established, the use of this class of drugs during pregnancy is justified only if the benefit to the mother clearly outweighs the possible harm to the fetus.

The GKS should not be used for long periods or in high doses during pregnancy.

As it has not yet been determined whether GCS may penetrate into breast milk with topical administration and systemic absorption, a decision should be made to discontinue breastfeeding or to discontinue the drug, given the need for its use in the mother.

Similarities